Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
Main Author: | Frontiers Production Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1289307/full |
Similar Items
-
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
by: Tatsuhiko Wada, et al.
Published: (2023-05-01) -
Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial
by: Ananda Wijewickrema, et al.
Published: (2024-07-01) -
Ivermectin drug induced liver injury
by: Mark Sonderup, et al.
Published: (2023-06-01) -
Increased risk of psychosis to ivermectin treatment
by: A. Romero Calderon, et al.
Published: (2022-06-01) -
Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study
by: Nasikarn Angkasekwinai, et al.
Published: (2022-06-01)